166 related articles for article (PubMed ID: 35760469)
21. [Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies].
Guillaume Z; Allory Y; Auclin E; Gervais C; Auvray M; Rochand A; Mejean A; Audenet F; Vano YA; Oudard S; Thibault C
Bull Cancer; 2023 Apr; 110(4):450-462. PubMed ID: 36906403
[TBL] [Abstract][Full Text] [Related]
22. Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.
Angori S; Banaei-Esfahani A; Mühlbauer K; Bolck HA; Kahraman A; Karakulak T; Poyet C; Feodoroff M; Potdar S; Kallioniemi O; Pietiäinen V; Schraml P; Moch H
Eur Urol Focus; 2023 Sep; 9(5):751-759. PubMed ID: 36933996
[TBL] [Abstract][Full Text] [Related]
23. An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC).
D'Angelo A; Bagby S; Di Pierro G; Chirra M; Nobili S; Mini E; Villari D; Roviello G
Crit Rev Oncol Hematol; 2020 May; 149():102921. PubMed ID: 32172222
[TBL] [Abstract][Full Text] [Related]
24. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
[TBL] [Abstract][Full Text] [Related]
25. A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma.
Osterman CK; Rose TL
Kidney Cancer; 2020; 4(1):15-27. PubMed ID: 34435168
[TBL] [Abstract][Full Text] [Related]
26. A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma.
Ismail S; Meskawi M; Hansen J; Bianchi M; Tian Z; Latour M; Graefen M; Montorsi F; Trinh QD; Perrotte P; Karakiewicz PI; Sun M
Crit Rev Oncol Hematol; 2014 Apr; 90(1):49-57. PubMed ID: 24411587
[TBL] [Abstract][Full Text] [Related]
27. Papillary renal cell carcinoma: current progress and future directions.
Twardowski PW; Mack PC; Lara PN
Clin Genitourin Cancer; 2014 Apr; 12(2):74-9. PubMed ID: 24629521
[TBL] [Abstract][Full Text] [Related]
28. Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview.
Bergmann L; Weber S; Hartmann A; Ahrens M
Expert Rev Anticancer Ther; 2021 Nov; 21(11):1273-1286. PubMed ID: 34291700
[No Abstract] [Full Text] [Related]
29. Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?
Trevisani F; Floris M; Vago R; Minnei R; Cinque A
Cells; 2022 May; 11(10):. PubMed ID: 35626699
[TBL] [Abstract][Full Text] [Related]
30. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.
Chahoud J; Msaouel P; Campbell MT; Bathala T; Xiao L; Gao J; Zurita AJ; Shah AY; Jonasch E; Sharma P; Tannir NM
Oncologist; 2020 Mar; 25(3):252-258. PubMed ID: 32162795
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Vogelzang NJ; Olsen MR; McFarlane JJ; Arrowsmith E; Bauer TM; Jain RK; Somer B; Lam ET; Kochenderfer MD; Molina A; Doshi G; Lingerfelt B; Hauke RJ; Gunuganti V; Schnadig I; Van Veldhuizen P; Fleming M; Galamaga R; Gupta M; Hool H; Hutson T; Zhang J; McHenry MB; Johansen JL; Tykodi SS
Clin Genitourin Cancer; 2020 Dec; 18(6):461-468.e3. PubMed ID: 32718906
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract][Full Text] [Related]
34. [MiT family translocation renal cell carcinomas: Natural history, molecular features and multidisciplinary management].
Herrscher H; Boilève A; Lindner V; Barthélémy P; Hutt É; Pierard L; Kurtz JE; Rioux-Leclercq N; Lang H; Malouf GG
Bull Cancer; 2020 Feb; 107(2):272-280. PubMed ID: 32044098
[TBL] [Abstract][Full Text] [Related]
35. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
36. Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.
de Vries-Brilland M; Gross-Goupil M; Seegers V; Boughalem E; Beuselinck B; Thibault C; Chevreau C; Ladoire S; Barthélémy P; Negrier S; Borchiellini D; Huillard O; Geoffrois L; Gravis G; Saldana C; Thiery-Vuillemin A; Escudier B; Ravaud A; Albiges L
Eur J Cancer; 2020 Sep; 136():76-83. PubMed ID: 32653774
[TBL] [Abstract][Full Text] [Related]
37. The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review.
Sneed GT; Lee S; Brown JN; Hammond JM
Clin Genitourin Cancer; 2019 Dec; 17(6):419-424. PubMed ID: 31585694
[TBL] [Abstract][Full Text] [Related]
38. Metastatic non-clear cell renal cell carcinoma: current therapeutic options.
Schrader AJ; Olbert PJ; Hegele A; Varga Z; Hofmann R
BJU Int; 2008 Jun; 101(11):1343-5. PubMed ID: 18241246
[TBL] [Abstract][Full Text] [Related]
39. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria.
Kroeger N; Xie W; Lee JL; Bjarnason GA; Knox JJ; Mackenzie MJ; Wood L; Srinivas S; Vaishamayan UN; Rha SY; Pal SK; Yuasa T; Donskov F; Agarwal N; Kollmannsberger CK; Tan MH; North SA; Rini BI; Choueiri TK; Heng DY
Cancer; 2013 Aug; 119(16):2999-3006. PubMed ID: 23696129
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the systemic treatment of metastatic non-clear cell renal cell carcinomas.
Ito K
Int J Urol; 2019 Sep; 26(9):868-877. PubMed ID: 31183903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
